Invention Grant
- Patent Title: ApoIII and the treatment and diagnosis of diabetes
- Patent Title (中): ApoIII和糖尿病的治疗和诊断
-
Application No.: US13935825Application Date: 2013-07-05
-
Publication No.: US08716241B2Publication Date: 2014-05-06
- Inventor: Per-Olof Berggren
- Applicant: BioCrine AB
- Applicant Address: SE Stockholm
- Assignee: BioCrine AB
- Current Assignee: BioCrine AB
- Current Assignee Address: SE Stockholm
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Main IPC: A61K38/14
- IPC: A61K38/14 ; A61K38/16 ; A61K49/00
Abstract:
The present invention provides methods of identifying candidate compounds for the treatment of type I diabetes and also provides methods for treating patients with type I diabetes and for limiting pancreatic beta cell apoptosis. The present invention also provides methods for diagnosing type I diabetes or a propensity to develop type I diabetes and methods for identifying diabetic patients to be treated with anti-apoCIII therapy.
Public/Granted literature
- US20130280816A1 ApoIII and the Treatment and Diagnosis of Diabetes Public/Granted day:2013-10-24
Information query
IPC分类:
